_HOME | _RSS
Titulares de Noticias Populares
|
Tackling tuberculosis: progress made and challenges remaining for the European Union
Miércoles, 19 Marzo, 2008 - 07:37 - 8 meses hace - 147 lecturas - Presse spécialisée - Eurosurveillance World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings on the causing agent of tuberculosis (TB) - Mycobacterium tuberculosis. This celebration provides a good opportunity to take stock of the achievements in controlling the disease so far - and the ... |
|
Demographic features and trends in tuberculosis cases in the European Region, 1995-2005
Miércoles, 19 Marzo, 2008 - 07:37 - 8 meses hace - 147 lecturas - Presse spécialisée - Eurosurveillance In the enlarged European Union (EU-27) and other western countries - where 19% of cases were of foreign origin in 2005 (>50% in 13 countries) - overall TB notification rates decreased by 2.4% yearly between 2000 and 2005, compared to 1.6% in 1995-2000, reflecting a declining incidence in all age ... |
|
A Framework Action Plan to fight Tuberculosis in the European Union
Miércoles, 19 Marzo, 2008 - 07:37 - 8 meses hace - 145 lecturas - Presse spécialisée - Eurosurveillance In March 2007 the EU Health Commissioner called on the European Centre for Disease Prevention and Control (ECDC) to work on a proposal for an action plan to fight TB in the EU. Following the call, the ECDC has developed a 'Framework Action Plan to fight Tuberculosis in the European Union'. T... |
|
The added value of a European Union tuberculosis reference laboratory network – analysis of the national reference laboratory activities
Miércoles, 19 Marzo, 2008 - 07:37 - 8 meses hace - 144 lecturas - Presse spécialisée - Eurosurveillance National reference laboratories (NRL) and other laboratories are the cornerstones of well-functioning tuberculosis programmes and surveillance activities. However, the scope and activity of NRL services for mycobacterial identification and drug susceptibility testing (DST) has not been examined in d... |
|
Magnesium Linked to Lower Ischemic Stroke Risk in Male Smokers
Jueves, 13 Marzo, 2008 - 02:00 - 8 meses, 1 semana hace - 122 lecturas - Presse spécialisée - Medscape family medicine A high magnesium intake may reduce the risk for primary ischemic stroke among male smokers, a study suggests. Medscape Medical News |
|
FDA Approvals: Nexium, Humira, Xyntha
Jueves, 13 Marzo, 2008 - 03:00 - 8 meses, 1 semana hace - 118 lecturas - Presse spécialisée - Medscape family medicine The FDA has approved an expanded indication for esomeprazole magnesium, a new indication for adalimumab subcutaneous injection, and antihemophilic factor plasma/albumin-free intravenous infusion. Medscape Medical News |
|
Sanofi-Aventis : la FDA enregistre le 1er vaccin humain contre - Boursier.com
Martes, 17 Abril, 2007 - 12:41 - 1 año, 7 meses hace - 114 lecturas - Presse généraliste - Google santé france (Boursier.com) - Sanofi pasteur, la division vaccins de Sanofi-Aventis, a annoncé ce mardi soir que la Food and Drug Administration américaine (FDA) avait enregistré son vaccin contre le virus H5N1, le 1er vaccin humain contre la grippe aviaire ... |
|
Smoking, Hypertension Have Synergistic Effect on Hemorrhagic Stroke Risk
Jueves, 13 Marzo, 2008 - 02:00 - 8 meses, 1 semana hace - 114 lecturas - Presse spécialisée - Medscape family medicine An analysis of combined cohorts shows that smoking and hypertension have a synergistic effect on hemorrhagic stroke risk, suggesting that treating them both at once may have an added positive effect. Medscape Medical News |
|
Raltegravir May Be Safe, Effective in Treating Multidrug-Resistant HIV
Viernes, 13 Abril, 2007 - 09:00 - 1 año, 7 meses hace - 113 lecturas - Presse spécialisée - Medscape HIV AIDS In treatment-refractory patients, this HIV-1 integrase inhibitor at all doses studied provided better viral suppression than placebo when added to an optimized background regimen. Medscape Medical News Laurie Barclay |
|
Gabapentin No More Effective Than Placebo for Tinnitus Relief
Martes, 17 Abril, 2007 - 09:00 - 1 año, 7 meses hace - 109 lecturas - Presse spécialisée - Medscape family medicine In a randomized trial, the gabapentin and placebo groups did not differ in their overall degree of life disturbance due to tinnitus or their overall impression of change in tinnitus. (CME) Medscape Medical News |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 30 – 40 – 50 – 60 – 70 – 80 – 90 – 100 – 110 – 120 – 130 – 140 – 150 – 160 – 170 – 180 – 190 – 200 – 210 – 220 – 230 – 240 – 250 – 260 – 270 – 280 – 290 – 300 – 310 – 320 >
